BIRC3/CAV1 co-expression drives GBM aggressiveness as a prognostic signature and therapeutic vulnerability

Abstract Glioblastoma (GBM) is an incurable tumor where temozolomide (TMZ) resistance limits survival, even in MGMT-methylated patients. To improve stratification, we used NAD(P)H-FLIM to profile TMZ response in 35 patient-derived explants, integrating these data with transcriptomic and functional a...

全面介紹

書目詳細資料

Principais autores:	Sara Franceschi, Mariangela Morelli, Francesca Lessi, Francesca Di Lorenzo, Paolo Aretini, Aldo Pastore, Andrea Marranci, Carlo Gambacciani, Francesco Pieri, Federico Villanacci, Nicola Montemurro, Manuel Giacomarra, Michele Menicagli, Gianmarco Ferri, Francesco Pasqualetti, Marco Krengli, Marc Sanson, Alberto Picca, Anna Luisa Di Stefano, Orazio Santo Santonocito, Chiara Maria Mazzanti
格式:	Artigo
語言:	Inglês
出版:	Nature Publishing Group 2026-04-01
叢編:	Cell Death Discovery
在線閱讀:	https://doi.org/10.1038/s41420-026-03112-z
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!